West Pharmaceutical Services Inc BDR (W2ST34)

Currency in BRL
66.64
+17.42(+35.38%)
Delayed Data·
Unusual trading volume
Trading near 52-week High
W2ST34 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
66.4066.65
52 wk Range
34.4766.65
Key Statistics
Bid/Ask
66.36 / 66.71
Prev. Close
49.25
Open
66.4
Day's Range
66.4-66.65
52 wk Range
34.47-66.65
Volume
528
Average Volume (3m)
1
1-Year Change
63.8495%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
W2ST34 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
Oct 29, 2026
EPS / Forecast
3.02 / --
Revenue / Forecast
874.5M / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 46.29
Dividend Yield
-
Industry Median 1.23%
Annualised payout
0.10
Paid quarterly
5-Years Growth
+5.29%
Growth Streak

W2ST34 Income Statement

Compare W2ST34 to Peers and Sector

Metrics to compare
W2ST34
Peers
Sector
Relationship
P/E Ratio
45.0x26.2x−0.2x
PEG Ratio
0.00−1.410.00
Price/Book
9.7x2.6x2.6x
Price / LTM Sales
8.5x2.7x2.8x
Upside (Analyst Target)
-17.4%63.4%
Fair Value Upside
Unlock8.2%9.5%Unlock

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.

Employees
10800
Market
Brazil

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
39.14M56.19%1.93B
Other Institutional Investors
33.07M43.81%1.63B
Public Companies & Retail Investors
0.000.00%0.00
Total
72.21M100.00%3.56B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.9.55%6,651,784327,600
Vanguard Capital Management, LLC7.19%5,009,736246,729

FAQ

What Is the West Pharmaceutical Services BDR (W2ST34) Stock Price Today?

The West Pharmaceutical Services BDR stock price today is 66.64 BRL.

What Stock Exchange Does West Pharmaceutical Services BDR Trade On?

West Pharmaceutical Services BDR is listed and trades on the B3 Stock Exchange.

What Is the Stock Symbol for West Pharmaceutical Services BDR?

The stock symbol for West Pharmaceutical Services BDR is "W2ST34."

What Is the West Pharmaceutical Services BDR Market Cap?

As of today, West Pharmaceutical Services BDR market cap is 161.56B BRL.

What Is West Pharmaceutical Services BDR's Earnings Per Share (TTM)?

The West Pharmaceutical Services BDR EPS (TTM) is 46.29.

From a Technical Analysis Perspective, Is W2ST34 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has West Pharmaceutical Services BDR Stock Split?

West Pharmaceutical Services BDR has split 0 times.

How Many Employees Does West Pharmaceutical Services BDR Have?

West Pharmaceutical Services BDR has 10800 employees.

What is the current trading status of West Pharmaceutical Services BDR (W2ST34)?

As of Nov 13, 2026, West Pharmaceutical Services BDR (W2ST34) is trading at a price of 66.64 BRL, with a previous close of 49.25 BRL. The stock has fluctuated within a day range of 66.40 BRL to 66.65 BRL, while its 52-week range spans from 34.47 BRL to 66.65 BRL.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2026 - Fusion Media Limited. All Rights Reserved.